Key inhibitor for use in proteasome research.
A potent and selective irreversible proteasome inhibitor. Specifically inhibits 20S proteasome (MCP; multicatalytic complex). Blocks proteasome activity by targeting the catalytic β-subunit. Has no effect on serine or cysteine proteases. Induces apoptosis inhuman monoblast U937 cells. Inhibits NF-κB activation by inhibiting IκB degradation (IC50=10 µM). Inhibits the ubiquitin proteasome pathway in cell culture. Inhibits cathepsin A. Upregulates HSP70 and HSP22, suggesting an initial neuroprotective pathway. Induces neurite outgrowth in Neuro 2A mouse neuroblastoma cells.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Appearance |
White to off-white solid. |
---|---|
CAS |
133343-34-7 |
Couple Target |
Proteasome 26S |
Couple Type |
Inhibitor |
Formula |
C15H24N2O7S |
Identity |
Determined by 1H-NMR and MS. |
MW |
376.4 |
Purity |
≥97% (HPLC) |
Solubility |
Soluble in water (10mg/ml), 100% ethanol (1mg/ml), methanol, DMSO (20mg/ml), dimethyl formamide (20mg/ml) or acetonitrile (20mg/ml). |
Source |
Synthetic |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. Organic stock solutions are stable for 3 months when stored at -20°C. Subject to hydrolysis in aqueous buffers. We do not recommend storing aqueous solutons for more than one day. |
---|---|
Handling |
Protect from light. Avoid freeze/thaw cycles. |
Long Term Storage |
-20°C |
Shipping |
Ambient Temperature |
Regulatory Status |
RUO – Research Use Only |
---|
- High-throughput screening identifies a novel small-molecule modulator of Hsp70 that selectively enhances ubiquitination and degradation of misfolded neuronal NO synthase: Garcia, A. M., Davis, A. K., et al.; Mol. Pharmacol. 107, 100008 (2025), Abstract
- Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity: Opland, C. K., Bryan, M. R., et al.; iScience 26, 106905 (2023), Abstract
- Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3: H. Luo, et al.; Front. Mol. Neurosci. 16, 1154203 (2023), Abstract
- Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation: J.Y. Yoon, et al.; Int. J. Mol. Sci. 23, 17 (2022), Abstract
- Chaperone-mediated autophagy regulates adipocyte differentiation: S. Kaushik, et al.; Sci. Adv. 8, eabq2733 (2022), Abstract
- EDEM1 Regulates Amyloid Precursor Protein (APP) Metabolism and Amyloid-β Production: J. Nowakowska-Gołacka, et al.; Int. J. Mol. Sci. 23, 117 (2022), Abstract
- KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP: M. Abeditashi, et al.; Cell. Mol. Life Sci. 79, 401 (2022), Abstract
- Supplementation with uric and ascorbic acid protects stored red blood cells through enhancement of non-enzymatic antioxidant activity and metabolic rewiring: V.L. Tzounakas, et al.; Redox Biol. 57, 102477 (2022), Abstract
- Red Blood Cell Proteasome in Beta-Thalassemia Trait: Topology of Activity and Networking in Blood Bank Conditions: A.T. Anastasiadi, et al.; Membranes 11, 716 (2021), Abstract
- Reduced Liver Autophagy in High-Fat Diet Induced Liver Steatosis in New Zealand Obese Mice: Korovila, I., Höhn, A., et al.; Antioxidants (Basel) 10, (2021), Abstract
- Mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC: Liu, Y. T., Sliter, D. A., et al.; Autophagy 17, 3753 (2021), Abstract
- HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue: Hauffe, R., Rath, M., et al.; Mol. Metab. 53, 101276 (2021), Abstract
- Males and Females Differ in the Subcellular and Brain Region Dependent Regulation of Proteasome Activity by CaMKII and Protein Kinase A: R.K. Devulapalli, et al.; Neuroscience 418, 1 (2019), Abstract
- Shifting the balance of autophagy and proteasome activation reduces proteotoxic cell death: a novel therapeutic approach for restoring photoreceptor homeostasis: Qiu, Y., Yao, J., et al.; Cell Death Dis. 10, 547 (2019), Abstract
- An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity: Schmidt, N., Domingues, P., et al.; PNAS 116, 17399 (2019), Abstract
- Inhibiting autophagy reduces retinal degeneration caused by protein misfolding: Yao, J., Qiu, Y., et al.; Autophagy 14, 1226 (2018), Abstract
- Functional analysis of Brassica napus phloem protein and ribonucleoprotein complexes: A. Ostendorp, et al.; New Phytol. 214, 1188 (2017), Application(s): Proteasome inhibition in phloem sap, Abstract — Full Text
- A leptospiral AAA+ chaperone-Ntn peptidase complex, HslUV, contributes to the intracellular survival of Leptospira interrogans in hosts and the transmission of leptospirosis: S.L. Dong, et al.; Emerg. Microbes Infect. 6, e105 (2017), Abstract — Full Text
- 18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer’s Disease Progression in Caenorhabditis elegans and Neuronal Cultures: Papaevgeniou, N., Sakellari, M., et al.; Antioxid. Redox Signal. 25, 855 (2016), Abstract
- AMPK-dependent phosphorylation of lipid droplet protein PLIN2 triggers its degradation by CMA: Kaushik, S., Cuervo, A. M., et al.; Autophagy 12, 432 (2016), Abstract
- The Molecular Chaperone Hsp70 Promotes the Proteolytic Removal of Oxidatively Damaged Proteins by the Proteasome: S. Reeg, et al.; Free Radic. Biol. Med. 99, 153 (2016), Application(s): Immunoblot Analysis, Abstract
- Comparative Proteomics Reveals Strain-Specific β-TrCP Degradation via Rotavirus NSP1 Hijacking a Host Cullin-3-Rbx1 Complex: S. Ding, et al.; PLoS Pathology 12, e1005929 (2016), Application(s): Cell treatment for immunoprecipitation, Abstract — Full Text
- Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity: A. Rodríguez-García, et al.; Gene Ther. 22, 596 (2015), Application(s): Cell Injection, Abstract
- Signal transduction and downregulation of C-MET in HGF stimulated low and highly metastatic human osteosarcoma cells: K. Husmann, et al.; Biochem. Biophys. Res. Commun. 464, 1222 (2015), Application(s): Cell Culture, Abstract
- Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson’s disease: I.S. Pienaar, et al.; Mol. Neurodegener. 10, 47 (2015), Application(s): Cell Culture, Abstract — Full Text
- Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson’s is associated with histone acetylation and up-regulation of neurotrophic factors: I.F. Harrison, et al.; Br. J. Pharmacol. 172, 4200 (2015), Application(s): Cell Culture, Abstract
- Associated Degeneration of Ventral Tegmental Area Dopaminergic Neurons in the Rat Nigrostriatal Lactacystin Model of Parkinsonism and their Neuroprotection by Valproate: I.F. Harrison, et al.; Neurosci. Lett. 614, 16 (2015), Application(s): Stereotaxic lesioning of the SNpc, Abstract
- Ubiquitination and proteasomal degradation of ATG12 regulates its proapoptotic activity: Haller, M., Hock, A. K., et al.; Autophagy 10, 2269 (2015), Abstract
- Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity: P.F. Lindholm, et al.; J. Clin. Cell. Immunol. 6, 308 (2015), Application(s): Cell Culture, Abstract — Full Text
- Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis: Okon, I. S., Coughlan, K. A., et al.; J. Clin. Invest. 124, 4590 (2014), Abstract
- Assessment of Cytokine-Modulated Proteasome Activity: C.J. Kirk, et al.; Methods Mol. Biol. 1172, 147 (2014), Abstract
- Cyclin C is a haploinsufficient tumour suppressor: Li, N., Fassl, A., et al.; Nat. Cell Biol. 16, 1080 (2014), Abstract
- Protochlamydia induces apoptosis of human HEp-2 cells through mitochondrial dysfunction mediated by chlamydial protease-like activity factor: Matsuo, J., Nakamura, S., et al.; PLoS One 8, e56005 (2013), Abstract
- CDK6 binds and promotes the degradation of the EYA2 protein: Kohrt, D., Crary, J., et al.; Cell Cycle 13, 62 (2013), Abstract
- Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62: D.H. Ball, et al.; J. Parasitol. Res. 2013, 961268 (2013), Abstract — Full Text
- Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28: M. Hernebring, et al.; Sci. Rep. 3, 1381 (2013), Abstract — Full Text
- Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization: T.T. Leskelä, et al.; J. Biol. Chem. 287, 5008 (2012), Abstract — Full Text
- Protein carbonylation and aggregation precede neuronal apoptosis induced by partial glutathione depletion: A. Dasgupta, et al.; ASN Neuro 4, e00084 (2012), Abstract — Full Text
- Novel Cell- and Tissue-Based Assays for Detecting Misfolded and Aggregated Protein Accumulation Within Aggresomes and Inclusion Bodies: D. Shen, et al.; Cell Biochem. Biophys. 60, 173 (2011), Abstract — Full Text
- Cell surface rescue of kidney anion exchanger 1 mutants by disruption of chaperone interactions: S.T. Patterson, et al.; J. Biol. Chem. 285, 33423 (2010), Abstract — Full Text
- Secretion stimulates intramembrane proteolysis of a secretory granule membrane enzyme: Rajagopal, C., Stone, K. L., et al.; J. Biol. Chem. 285, 34632 (2010), Abstract
- Role of high-mobility group box 1 protein and poly(ADP-ribose) polymerase 1 degradation in Chlamydia trachomatis-induced cytopathicity: Yu, H., Schwarzer, K., et al.; Infect. Immun. 78, 3288 (2010), Abstract
- HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2: Scognamiglio, A., Nebbioso, A., et al.; Biochim. Biophys. Acta 1783, 2030 (2008), Abstract
- Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis: E.H. Yew et al.; J. Neurochem. 94, 943 (2005), Abstract
- Effect of geldanamycin on androgen receptor function and stability: Vanaja, D. K., Mitchell, S. H., et al.; Cell Stress Chaperones 7, 55 (2002), Abstract
- Lactacystin inhibits cathepsin A activity in melanoma cell lines: L. Kozlowski, et al.; Tumour Biol. 22, 211 (2001), Abstract
- Lactacystin, a proteasome inhibitor: discovery and its application in cell biology: H.Tomoda & S. Omura; Yakugaku Zasshi 120, 935 (2000), Abstract
- Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells: L.A. Pasquini, et al.; J. Neurosci. Res. 59, 601 (2000), Abstract
- Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons: J.H. Qiu, et al.; J. Neurosci. 20, 259 (2000), Abstract
- Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas-resistant adult T-cell leukemia cell lines: Y. Yamada, et al.; Eur. J. Haematol. 64, 315 (2000), Abstract
- Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome: H. Ostrowska, et al.; Int. J. Biochem. Cell. Bio. 32, 747 (2000), Abstract
- Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression: D. Kim, et al.; Biochem. Biophys. Res. Commun. 254, 264 (1999), Abstract
- Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells: H. Kitagawa, et al.; FEBS Lett. 443, 181 (1999), Abstract
- The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis: J. Delic, et al.; Br. J. Cancer 77, 1103 (1998), Abstract
- Lactacystin, proteasome function, and cell fate: G. Fenteany & S.L. Schreiber; J. Biol. Chem. 273, 8545 (1998), Abstract
- The role of proteolysis during differentiation of Trypanosoma brucei from the bloodstream to the procyclic form: M.C. Mutomba & C.C. Wang; Mol. Biochem. Parasitol. 93, 11 (1998), Abstract
- Proteasome inhibitors prevent the degradation of familial Alzheimer’s disease-linked presenilin 1 and potentiate A beta 42 recovery from human cells: P. Marambaud, et al.; Mol. Med. 4, 147 (1998), Abstract
- Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation: A. Craiu, et al.; J. Biol. Chem. 272, 56 (1997), Abstract
- Degradation of 3-hydroxy-3-methylglutaryl-CoA reductase in endoplasmic reticulum membranes is accelerated as a result of increased susceptibility to proteolysis: T.P. McGee, et al.; J. Biol. Chem. 271, 25630 (1996), Abstract
- Novel inhibitors of the proteasome and their therapeutic use in inflammation: J. Adams & R. Stein; Annual Rep. Med. Chem. 31, 279 (1996)
- Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway: H. Yoshida, et al.; Cancer Res. 56, 2945 (1996), Abstract
- Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells: Y. Murakami, et al.; Biochem. J. 317, 77 (1996), Abstract
- Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity: D. Qu, et al.; J Biol Chem 271, 22791 (1996), Abstract
- Lactacystin, an inhibitor of the proteasome, blocks the degradation of a mutant precursor of glycosylphosphatidylinositol-linked protein in a pre-Golgi compartment: K. Oda, et al.; Biochem. Biophys. Res. Commun. 219, 800 (1996), Abstract
- Proteasome-dependent regulation of p21WAF1/CIP1 expression: M.V. Blagosklonny, et al.; Biochem. Biophys. Res. Commun. 227, 564 (1996), Abstract
- Lactacystin increases LDL receptor level on HepG2 cells: H. Miura, et al.; Biochem. Biophys. Res. Commun. 227, 684 (1996), Abstract
- Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors: E. Fujita, et al.; Biochem. Biophys. Res. Commun. 224, 74 (1996), Abstract
- The neuritogenesis inducer lactacystin arrests cell cycle at both G0/G1 and G2 phases in neuro 2a cells: M. Katagiri, et al.; J. Antibiot. (Tokyo) 48, 344 (1995), Abstract
- Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells: S. Imajoh-Ohmi, et al.; Biochem. Biophys. Res. Commun. 217, 1070 (1995), Abstract
- Degradation process of ligand-stimulated platelet-derived growth factor beta-receptor involves ubiquitin-proteasome proteolytic pathway: S. Mori, et al.; J. Biol. Chem. 270, 29447 (1995), Abstract
- Structure-activity relationships of lactacystin, the first non-protein neurotrophic factor: T. Nagamitsu et al.; J Antibiot (Tokyo) 48, 747 (1995), Abstract
- Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid: H. Tanaka et al.; Biochem. Biophys. Res. Commun. 216, 291 (1995), Abstract
- Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin: G. Fenteany, et al.; Science 268, 726 (1995), Abstract
- A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line: G. Fenteany, et al.; PNAS 91, 3358 (1994), Abstract
- Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells: S. Omura, et al.; J. Antibiot. (Tokyo) 44, 113 (1991), Abstract
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form